NCCR-TRANSCURE

The NCCR TransCure started on November 1st, 2010 and ended on October 31st, 2022. We are grateful to the Swiss National science Foundation, to our home institution - the Unibersity of Bern - and to everyone who contributed to the success of this network. The NCCR TransCure has been a perfect example of what science is in the 21st century: connecting ideas, collaborating with outstanding scientists, and educating the next generations of multidisciplinary researchers. We all made a huge footprint in the membrane transporter and ion channel research!... We are also proud of the NCCR TransCure spin-off Synendos Therapeutics, incorporated in 2019 and now on the way to the development of a promising compound for the treatment of stress-related neuropsychiatric disorders... Through research in the field of membrane biology, the NCCR-TransCure aims to better understand the mechanisms of common diseases like diabetes, hypertension, cancer and neurodegenerative disorders, and to thereby..

Primary location: Bern